Leval 20

Selective, strong inhibitor of Phosphodiesterase type 5 (PDE5) indicated for the treatment of patients with pulmonary arterial hypertension. By vasodilating the pulmonary vascular bed it improves exercise ability and delays clinical worsening

Therapeutic Area
Pulmonary hypertension

Active Ingredient

Pulmonary hypertension

Dosage forms
20 mg tablets x 30 and 60 units